NCT05582239 - Measure of Vaccine Effectiveness to Prevent Hospitalizations for Viral Respiratory Infections in Adults | Biotech Hunter

Enrollment

2,400

Participants

Timeline

Start Date

January 20, 2023

Primary Completion Date

January 20, 2026

Study Completion Date

January 20, 2026

Conditions

Severe Acute Respiratory Infection (SARI)InfluenzaCOVID-19

Trial Locations (8)

RECRUITING

Hôpital Cochin, Paris

RECRUITING

CHU, Dijon

RECRUITING

Groupement hospitalier Edouard Herriot, Lyon

RECRUITING

Hôpital Gui de Chauliac, Montpellier

RECRUITING

CHU, Nantes

RECRUITING

Hôpital Bichat, Paris

RECRUITING

CHU, Rennes

RECRUITING

CHU, Saint-Etienne